merck germany - Search News

SpringWorks, Merck

Germany's Merck in advanced talks to acquire US biotech firm SpringWorks

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) -Merck KGaA,

The Wall Street Journal on MSN · 20h

Germany’s Merck in Talks to Buy SpringWorks Therapeutics

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

BioSpace · 13h

Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.

Bloomberg L.P. · 1d

Merck KGaA in Talks to Buy SpringWorks Therapeutics

Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring.

Inc · 1d

Merck In Talks to Buy Cancer Drugmaker Springworks

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

Hosted on MSN · 1d

Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according to people familiar with the matter.

Business Wire20d

Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver ...

1don MSN

SpringWorks Stock Jumps More Than 30% on News of Possible Deal

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

Nasdaq24d

Lobbying Update: $80,000 of MERCK KGAA DARMSTADT GERMANY lobbying was just disclosed

$80,000 of MERCK KGAA DARMSTADT GERMANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to chemical ...

12d

Merck to stop lung condition drug study early due to strong efficacy data

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results